Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.57 CAD | +6.80% | -2.48% | -53.13% |
05-14 | Transcript : Aptose Biosciences Inc., Q1 2024 Earnings Call, May 14, 2024 | |
05-14 | Aptose Biosciences Q1 Net Loss Falls, on Lower Expenses | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-53.13% | 17.5M | |
+67.26% | 62.86B | |
-0.80% | 41.38B | |
+45.66% | 40.38B | |
-10.72% | 27.64B | |
+13.19% | 26.46B | |
-22.88% | 18.9B | |
+4.65% | 12.67B | |
+23.91% | 12.27B | |
+27.19% | 12.07B |
- Stock Market
- Equities
- APS Stock
- News Aptose Biosciences Inc.
- Aptose Biosciences to Present Data on Tuspetinib at Haematology Conference in Portugal